article thumbnail

Immuno-oncology market set to grow in billions, but access concerns remain

Pharmaceutical Technology

This high compound annual growth rate of 23.6% These figures are only expected to grow in the coming years, with sales forecasted to reach over $150 billion by 2028. In China, immuno-oncology agents manufactured by Western companies are often only accessible with private insurance, based on a Chinese KOL.

article thumbnail

4. Financial Wellness and the Medical School Cost Dilemma with Dr. Tim Ulbrich

The Physician Pharmacist

But that's going to grow and compound over many, many, many years. So a health savings account is available to those that have health care insurance through their employer through what's known as a High Deductible Health Plan, which is becoming more and more common. That's $100,000, right. But what the bank was willing to lend.